Literature DB >> 17291381

Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods.

D M Fleming1, A J Elliot, K W Cross.   

Abstract

We compared the burden of illness due to a spectrum of respiratory diagnostic categories among persons presenting in a sentinel general practice network in England and Wales during periods of influenza and of respiratory syncytial virus (RSV) activity. During all periods of viral activity, incidence rates of influenza-like illness, bronchitis and common cold were elevated compared to those in baseline periods. Excess rates per 100,000 of acute bronchitis were greater in children aged <1 year (median difference 2702, 95% CI 929-4867) and in children aged 1-4 years (994, 95% CI 338-1747) during RSV active periods rather than influenza; estimates for the two viruses were similar in other age groups. Excess rates of influenza-like illness in all age groups were clearly associated with influenza virus activity. For common cold the estimates of median excess rates were significantly higher in RSV active periods for the age groups <1 year (3728, 95% CI 632-5867) and 5-14 years (339, 95% CI 59-768); estimates were similar in other age groups for the two viruses. The clinical burden of disease associated with RSV is as great if not greater than influenza in patients of all ages presenting to general practitioners.

Entities:  

Mesh:

Year:  2007        PMID: 17291381      PMCID: PMC2870675          DOI: 10.1017/S0950268807007881

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  33 in total

1.  The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.

Authors:  D M Fleming; M Zambon; A I Bartelds; J C de Jong
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

Review 2.  Weekly Returns Service of the Royal College of General Practitioners.

Authors:  D M Fleming
Journal:  Commun Dis Public Health       Date:  1999-06

3.  Surveillance and impact of influenza in Europe. Groupe Régional d'Observation de la Grippe and European Influenza Surveillance Scheme.

Authors:  M Aymard; M Valette; B Lina; D Thouvenot
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

4.  Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

5.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

Authors:  L Simonsen; M J Clarke; L B Schonberger; N H Arden; N J Cox; K Fukuda
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

6.  Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

Authors:  K G Nicholson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

7.  Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses.

Authors:  J Stockton; J S Ellis; M Saville; J P Clewley; M C Zambon
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

8.  Respiratory syncytial virus infection in elderly and high-risk adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Christopher Cox; Edward E Walsh
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

9.  Respiratory syncytial virus or influenza?

Authors:  D M Fleming; K W Cross
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

10.  Respiratory syncytial virus and influenza A infections in the hospitalized elderly.

Authors:  A R Falsey; C K Cunningham; W H Barker; R W Kouides; J B Yuen; M Menegus; L B Weiner; C A Bonville; R F Betts
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  20 in total

1.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

2.  Increasing the complexity of respiratory syncytial virus infection: Reactive oxygen species, DNA damage, and premature senescence.

Authors:  Patrick Dumont
Journal:  Virulence       Date:  2016-03-23       Impact factor: 5.882

Review 3.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

Review 4.  Lessons from 40 years' surveillance of influenza in England and Wales.

Authors:  D M Fleming; A J Elliot
Journal:  Epidemiol Infect       Date:  2007-11-30       Impact factor: 2.451

5.  Is the onset of influenza in the community age-related?

Authors:  D M Fleming; H Durnall; F Warburton; J S Ellis; M C Zambon
Journal:  Epidemiol Infect       Date:  2016-08       Impact factor: 4.434

6.  Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old.

Authors:  David L McClure; Burney A Kieke; Maria E Sundaram; Melissa D Simpson; Jennifer K Meece; Frangiscos Sifakis; Robert A Gasser; Edward A Belongia
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

7.  Superinfection between influenza and RSV alternating patterns in San Luis Potosí State, México.

Authors:  Jorge Xicoténcatl Velasco-Hernández; Mayra Núñez-López; Andreu Comas-García; Daniel Ernesto Noyola Cherpitel; Marcos Capistrán Ocampo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

8.  Fatal cases of influenza a in childhood.

Authors:  Benjamin F Johnson; Louise E Wilson; Joanna Ellis; Alex J Elliot; Wendy S Barclay; Richard G Pebody; Jim McMenamin; Douglas M Fleming; Maria C Zambon
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

9.  A robust parameter estimation method for estimating disease burden of respiratory viruses.

Authors:  King Pan Chan; Chit Ming Wong; Susan S S Chiu; Kwok Hung Chan; Xi Ling Wang; Eunice L Y Chan; J S Malik Peiris; Lin Yang
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.

Authors:  Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde
Journal:  Influenza Other Respir Viruses       Date:  2014-06-27       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.